Our Access-to-Medicine Strategy
Four Cornerstones of the Access-to-Medicine Strategy
| Cornerstone | Description |
|---|---|
| 1. Empowering women, globally | Enable 100 million women in low- and middle-income countries with affordable modern contraceptives by 2030. Improve women's health, rights and economic status as a step towards increasing Gender Equality (SDG 5). |
| 2. Inclusive and sustainable growth | Pursue inclusive growth approaches from which many patients worldwide will benefit, connecting innovation with societal value and responsible business practices. |
| 3. Health system strengthening and capacity building | Support training, awareness, diagnosis, capacity building and locally relevant delivery models in LMICs, working with governments, NGOs and healthcare providers. |
| 4. Product development with structured access planning | Integrate access planning into the product lifecycle, preparing holistic patient access plans for pipeline assets no later than Phase II, considering global health perspective, burden of disease in LMICs and local access strategies. |
Tackling Affordability: Equitable Pricing Approach
When it comes to access to medicine, cost can be a major barrier. Affordability can vary greatly across countries and regions. Bayer believes that this should be taken into consideration as the company aims to deliver more access to medicines to more patients worldwide.
Bayer is transforming the way it prices products. The new pharmaceutical pricing philosophy amalgamates local ability-to-pay with product value to provide patients in need with access. The pricing philosophy takes into consideration local affordability and the value of the products to offer greater pricing flexibility to countries' national health systems. This approach was rolled out worldwide in 2021.
Key features of the equitable pricing approach
- Local ability-to-pay is combined with product value to determine pricing
- National income level is considered in the pricing strategy for all newly launched brands and nine legacy global brands
- Greater pricing flexibility is offered to countries' national health systems
- The approach was rolled out worldwide in 2021
Our Partnerships
To realize its goals, Bayer works together with a wide range of private and public organizations to understand their perspectives, define targets and make an impact at scale.